Close

Drug Research

Airway Therapeutics and Celonic Group Collaborate to Produce AT-100 as Promising New Candidate for Coronavirus

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, and Celonic Group, a premium biopharmaceutical CDMO specialized in the development and...

Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that the companies have entered into a collaboration agreement to develop EIDD-2801, an orally available antiviral candidate currently in...

Leinco Technologies and Vanderbilt University Medical Center partner to deliver rapid, point of care COVID-19 diagnostic test

Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, conjugates and provider of custom manufacturing services to the diagnostic and biopharmaceutical industries, today announced an agreement with Vanderbilt University Medical Center (VUMC) to scale up...

Catalent Signs Development Agreement with Ennaid Therapeutics on its COVID-19 Lead Program

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at COVID-19....

Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration

Regeneron Pharmaceuticals, Inc. and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced a large-scale research collaboration designed to advance the field of human genetics and precision medicine through the sharing of...

Pfizer Outsources Branded Drug Production to Focus on Experimental Coronavirus Vaccine

Pfizer is taking on significant risk in a race to provide the world with a coronavirus vaccine. Pfizer is outsourcing the production of its own branded medicines to contract manufacturers such as Catalent to make room for the production...

Vault Health Delivers Access to the First FDA EUA Approved At-Home Saliva Test for COVID-19

For the first time, Americans will have access to at-home testing for COVID-19 through Vault Health, utilizing the first FDA EUA approved saliva test from RUCDR Infinite Biologics and Spectrum Solutions. Vault Health, a startup specializing in healthcare for men,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read